Cancer Therapy News and Research

RSS

UTA scientist receives $1.17 million grant for cancer research

A scientist's research at The University of Texas at Arlington could lead to more effective, targeted treatment of cancer cells--adding to the University's diverse array of projects focused on advancing health and the human condition.

15 Apr 2019

Scientists present a new approach to fight cancer

In recent years, it's become clear that RNA-binding proteins play a major role in cancer growth. These proteins, active in all cells but especially so in cancer cells, bind to RNA molecules and accelerate cancer cell growth.

15 Apr 2019

FDA approves new treatment for adults with metastatic bladder cancer

The U.S. Food and Drug Administration today granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration known as FGFR3 or FGFR2, and that has progressed during or following prior platinum-containing chemotherapy.

12 Apr 2019

Combined inhibition of EGFR and c-RAF kinase shows regression of most aggressive pancreatic cancer

Researchers from the Experimental Oncology Group, led by Mariano Barbacid at the Spanish National Cancer Research Centre, have published in Cancer Cell the results of a study that shows full regression of advanced pancreatic ductal adenocarcinoma upon combined inhibition of the epidermal growth factor receptor and c-RAF kinase.

12 Apr 2019

Study describes vulnerability shared by large subset of cancer cell lines

Cancer cells adapt to potentially fatal mutations and other molecular malfunctions by adjusting one or more other genes' activity, in the process becoming dependent on those genes for their survival and growth.

12 Apr 2019

New liquid biopsy technique used to assess melanoma progression

When the surgeon surgically removes a melanoma, some patients are said to be 'cancer-free' and they do not get additional treatment. However, should the fluid obtained in the drainage implanted after surgery be tested using the liquid biopsy technique rather than be disposed of as medical waste, the test might predict the high or low risk of cancer recurrence.

11 Apr 2019

Scientists aim to minimize or eliminate hair loss during cancer treatment

SCIENTISTS at the University of Huddersfield aim to minimize or eliminate completely, the hair loss that is one of the most distressing side-effects of cancer treatment.

11 Apr 2019

Cancer patients and those with anemia should not be denied opioids, says CDC

The U.S. CDC has issued a letter clarifying that people suffering from severe pain caused by cancer or sickle-cell anemia should not be denied prescriptions for opioid pain-killers.

11 Apr 2019

Genetics may play a role in developing cancer therapy-induced cardiomyopathy

Recent advances in the development of cancer therapies have increased long-term survival and prognosis.

10 Apr 2019

Proton therapy shows excellent outcomes, minimal side effects in high-risk neuroblastoma patients

Researchers from Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania analyzed the largest cohort to date of pediatric patients with high-risk neuroblastoma treated with proton radiation therapy, finding both that proton therapy was effective at reducing tumors and demonstrated minimal toxicity to surrounding organs.

10 Apr 2019

Single-cell sequencing sheds light on landscape of myeloid cells in lung tumors

The recent emergence of immunotherapy has marked a sea change in research and care for many forms of cancer, bringing new hope to patients and families around the world. For those who respond to treatment, the results can be dramatic.

10 Apr 2019

Biologists analyze available methods of targeted drug delivery to malignant tumors

A team of biologists from Sechenov First Moscow State Medical University and Lobachevsky University analyzed available methods of targeted drug delivery to malignant tumors.

9 Apr 2019

Study finds no statistically significant effect of drug shortages on cancer treatment

For the vast majority of cancer drugs experiencing shortages over a seven-year period, a new USC research study found no statistically significant effect of shortages on chemotherapy treatment.

8 Apr 2019

Varian presents first preclinical results of breakthrough cancer therapy research

At the American Association for Cancer Research Annual Meeting in Atlanta, GA, Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the Maryland Proton Treatment Center, presented publicly the first pre-clinical results of its research on ultra-high dose rate cancer treatments with protons.

From American Association for Cancer Research-AACR Annual Meeting 2019 8 Apr 2019

ASCO issues guideline recommending older adults with cancer to receive geriatric assessment

Although the majority of patients who have blood cancers are older adults, they make up only a small percentage of participants in the clinical trials that lead to new therapies.

8 Apr 2019

Study examines costs of cancer treatment associated with continued smoking

This study was an economic evaluation and it used a model to examine the costs of subsequent cancer treatment associated with continued smoking by patients after their initial cancer treatment failed.

8 Apr 2019

Study estimates economic burden of smoking on cancer treatment

A study released today in JAMA Network Open reported that smoking after a cancer diagnosis is associated with substantial additional costs of cancer treatment.

5 Apr 2019

FDA extends indication of metastatic breast cancer treatment to include male patients

The U.S. Food and Drug Administration today is extending the indication of Ibrance (palbociclib) capsules in combination with specific endocrine therapies for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in male patients.

5 Apr 2019

Researchers unravel 3D structure of key molecular target for cancer treatment

Columbia University scientists, in collaboration with researchers from Nimbus Therapeutics, have demystified a metabolic enzyme that could be the next major molecular target in cancer treatment.

4 Apr 2019

UB researchers develop new method to more accurately predict tumor growth rates

University at Buffalo researchers have developed a new method to more accurately predict tumor growth rates, a crucial statistic used to schedule screenings and set dosing regimens in cancer treatment.

4 Apr 2019

Cancer Therapy News and Research

UTA scientist receives $1.17 million grant for cancer research

Scientists present a new approach to fight cancer

FDA approves new treatment for adults with metastatic bladder cancer

Combined inhibition of EGFR and c-RAF kinase shows regression of most aggressive pancreatic cancer

Study describes vulnerability shared by large subset of cancer cell lines

New liquid biopsy technique used to assess melanoma progression

Scientists aim to minimize or eliminate hair loss during cancer treatment

Cancer patients and those with anemia should not be denied opioids, says CDC

Genetics may play a role in developing cancer therapy-induced cardiomyopathy

Proton therapy shows excellent outcomes, minimal side effects in high-risk neuroblastoma patients

Single-cell sequencing sheds light on landscape of myeloid cells in lung tumors

Biologists analyze available methods of targeted drug delivery to malignant tumors

Study finds no statistically significant effect of drug shortages on cancer treatment

Varian presents first preclinical results of breakthrough cancer therapy research

ASCO issues guideline recommending older adults with cancer to receive geriatric assessment

Study examines costs of cancer treatment associated with continued smoking

Study estimates economic burden of smoking on cancer treatment

FDA extends indication of metastatic breast cancer treatment to include male patients

Researchers unravel 3D structure of key molecular target for cancer treatment

UB researchers develop new method to more accurately predict tumor growth rates

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News